Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
Google ScholarÂ
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.
Google ScholarÂ
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.
Google ScholarÂ
Jokhadze N, Das A, Dizon DS. Global cancer statistics: a healthy population relies on population health. CA Cancer J Clin. 2024;74:224–6.
Google ScholarÂ
Gilles H, Garbutt T, Landrum J. Hepatocellular carcinoma. Crit Care Nurs Clin. 2022;34:289–301.
Anwanwan D, Singh SK, Singh S, Saikam V, Singh R. Challenges in liver cancer and possible treatment approaches. BBA Rev Cancer. 2020;1873:188314.
Google ScholarÂ
Wang Y, Deng B. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metast Rev. 2023;42:629–52.
Google ScholarÂ
Lawo S, Bashkurov M, Mullin M, Ferreria MG, Kittler R, Habermann B, et al. HAUS, the 8-subunit human Augmin complex, regulates centrosome and spindle integrity. Curr Biol. 2009;19:816–26.
Google ScholarÂ
Uehara R, Nozawa RS, Tomioka A, Petry S, Vale RD, Obuse C, et al. The augmin complex plays a critical role in spindle microtubule generation for mitotic progression and cytokinesis in human cells. Proc Natl Acad Sci USA. 2009;106:6998–7003.
Google ScholarÂ
Ho CM, Hotta T, Kong Z, Zeng CJ, Sun J, Lee YR, et al. Augmin plays a critical role in organizing the spindle and phragmoplast microtubule arrays in Arabidopsis. Plant Cell. 2011;23:2606–18.
Google ScholarÂ
Yao Q, Ge X, Lu Z, Shi J, Shen J, Chen J. HAUS Augmin-like complex subunit 1 Influences tumour microenvironment and prognostic outcomes in glioma. J Oncol. 2022;2022:8027686.
Google ScholarÂ
Tang L, Chen Z, Wei C, Liu H, Wang B, Yu T, et al. The significance of HAUS1 and its relationship with immune microenvironment in hepatocellular carcinoma. J Cancer. 2024;15:1328–41.
Google ScholarÂ
Wu X, Yang X, Xiong Y, Li R, Ito T, Ahmed TA, et al. Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders. Nat Cancer. 2021;2:429–43.
Google ScholarÂ
Jiang Q, Mai C, Yang H, Wu Q, Hua S, Yan C, et al. Nuclear expression of CDK4 correlates with disease progression and poor prognosis in human nasopharyngeal carcinoma. Histopathology. 2014;64:722–30.
Google ScholarÂ
Du Q, Guo X, Wang M, Li Y, Sun X, Li Q. The application and prospect of CDK4/6 inhibitors in malignant solid tumors. J Hematol Oncol. 2020;13:41.
Google ScholarÂ
Fassl A, Geng Y, Sicinski P. CDK4 and CDK6 kinases: from basic science to cancer therapy. Science. 2022;375:eabc1495.
Google ScholarÂ
Bai X, Guo ZQ, Zhang YP, Fan ZZ, Liu LJ, Liu L, et al. CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy. Nat Commun. 2023;14:1247.
Google ScholarÂ
Yang Y, Luo J, Chen X, Yang Z, Mei X, Ma J, et al. CDK4/6 inhibitors: a novel strategy for tumor radiosensitization. J Exp Clin Canc Res. 2020;39:188.
Google ScholarÂ
Hamilton E, Infante JR. Targeting CDK4/6 in patients with cancer. Cancer Treat Rev. 2016;45:129–38.
Google ScholarÂ
Sorokin AV, Kanikarla MP, Bitner L, Syed M, Woods M, Manyam G, et al. Targeting RAS mutant colorectal cancer with dual inhibition of MEK and CDK4/6. Cancer Res. 2022;82:3335–44.
Google ScholarÂ
Chen M, Chen W, Sun S, Lu Y, Wu G, Xu H, et al. CDK4/6 inhibitor PD-0332991 suppresses hepatocarcinogenesis by inducing senescence of hepatic tumor-initiating cells. J Adv Res. 2025;73:357–73.
Google ScholarÂ
Li P, Guo H, Wu K, Su L, Huang K, Lai R, et al. Decreased IL-37 expression in hepatocellular carcinoma tissues and liver cancer cell lines. Oncol Lett. 2020;19:2639–48.
Google ScholarÂ
Wei C, Wang B, Chen ZH, Xiao H, Tang L, Guan JF, et al. Validating RRP12 expression and its prognostic significance in HCC based on data mining and bioinformatics methods. Front Oncol. 2022;12:812009.
Google ScholarÂ
Sun S, Li Q, Liu G, Huang X, Li A, Guo H, et al. Endosomal protein DENND10/FAM45A integrates extracellular vesicle release with cancer cell migration. BMC Biol. 2024;22:154.
Google ScholarÂ
Wu H, Yan Y, Yuan J, Luo M, Wang Y. miR-4324 inhibits ovarian cancer progression by targeting FEN1. J Ovarian Res. 2022;15:32.
Google ScholarÂ
Xiong H, Xiao H, Luo C, Chen L, Liu X, Hu Z, et al. GRP78 activates the Wnt/HOXB9 pathway to promote invasion and metastasis of hepatocellular carcinoma by chaperoning LRP6. Exp Cell Res. 2019;383:111493.
Google ScholarÂ
Zhang Y, Li H, Chang H, Du L, Hai J, Geng X, et al. MTP18 overexpression contributes to tumor growth and metastasis and associates with poor survival in hepatocellular carcinoma. Cell Death Dis. 2018;9:956.
Google ScholarÂ
Liang J, Yang Y, Bai L, Li F, Li E. DRP1 upregulation promotes pancreatic cancer growth and metastasis through increased aerobic glycolysis. J Gastroen Hepatol. 2020;35:885–95.
Google ScholarÂ
Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98–W102.
Google ScholarÂ
Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastro Hepat. 2019;16:589–604.
Google ScholarÂ
Fu J, Wang H. Precision diagnosis and treatment of liver cancer in China. Cancer Lett. 2018;412:283–8.
Google ScholarÂ
Nevola R, Ruocco R, Criscuolo L, Villani A, Alfano M, Beccia D, et al. Predictors of early and late hepatocellular carcinoma recurrence. World J Gastroentero. 2023;29:1243–60.
Google ScholarÂ
Gong CF, Sun YK, Xie YB. Advances in molecular classification and precision immunotherapy for gastric cancer. Zhonghua Yi Xue Za Zhi. 2021;101:2649–52.
Google ScholarÂ
Nagaraju GP, Dariya B, Kasa P, Peela S, El-Rayes BF. Epigenetics in hepatocellular carcinoma. Semin Cancer Biol. 2022;86:622–32.
Google ScholarÂ
Cunha-Ferreira I, Chazeau A, Buijs RR, Stucchi R, Will L, Pan X, et al. The HAUS complex is a key regulator of non-centrosomal microtubule organization during neuronal development. CELL REP. 2018;24:791–800.
Google ScholarÂ
Goshima G, Mayer M, Zhang N, Stuurman N, Vale RD. Augmin: a protein complex required for centrosome-independent microtubule generation within the spindle. J Cell Biol. 2008;181:421–9.
Google ScholarÂ
Ustinova K, Ruhnow F, Gili M, Surrey T. Microtubule binding of the human augmin complex is directly controlled by importins and Ran-GTP. J Cell Sci. 2023;136:jcs261096.
Google ScholarÂ
Campregher PV, de Oliveira PW, Lisboa B, Puga R, Deolinda ER, Helman R, et al. A novel mechanism of NPM1 cytoplasmic localization in acute myeloid leukemia: the recurrent gene fusion NPM1-HAUS1. Haematologica. 2016;101:e287–e290.
Google ScholarÂ
Cheung S, Xie P, Rosenwaks Z, Palermo GD. Profiling the male germline genome to unravel its reproductive potential. Fertil Steril. 2023;119:196–206.
Google ScholarÂ
Csont T, Murlasits Z, Menesi D, Kelemen JZ, Bencsik P, Pipicz M, et al. Tissue-specific gene expression in rat hearts and aortas in a model of vascular nitrate tolerance. J Cardiovasc Pharm. 2015;65:485–93.
Google ScholarÂ
Zhao YP, Chen G, Feng B, Zhang TP, Ma EL, Wu YD. Microarray analysis of gene expression profile of multidrug resistance in pancreatic cancer. Chinese Med J. 2007;120:1743–52.
Google ScholarÂ
Wang T, Yao S, Li S, Fei X, Zhang M. A prognostic model based on the Augmin family genes for LGG patients. Sci Rep. 2023;13:7520.
Google ScholarÂ
Goel S, Bergholz JS, Zhao JJ. Targeting CDK4 and CDK6 in cancer. Nat Rev Cancer. 2022;22:356–72.
Google ScholarÂ
Lee HJ, Hoe HS. Inhibition of CDK4/6 regulates AD pathology, neuroinflammation and cognitive function through DYRK1A/STAT3 signaling. Pharmacol Res. 2023;190:106725.
Google ScholarÂ
Bahn YJ, Yadav H, Piaggi P, Abel BS, Gavrilova O, Springer DA, et al. CDK4-E2F3 signals enhance oxidative skeletal muscle fiber numbers and function to affect myogenesis and metabolism. J Clin Investig. 2023;133:e162479.
Google ScholarÂ
Goel S, DeCristo MJ, McAllister SS, Zhao JJ. CDK4/6 inhibition in cancer: beyond cell cycle arrest. Trends Cell Biol. 2018;28:911–25.
Google ScholarÂ
Kim S, Armand J, Safonov A, Zhang M, Soni RK, Schwartz G, et al. Sequential activation of E2F via Rb degradation and c-Myc drives resistance to CDK4/6 inhibitors in breast cancer. Cell Rep. 2023;42:113198.
Google ScholarÂ
Lai F, Fang Y, Cheng C, Zhong X, Zheng W, Lan S, et al. CDK4 as a prognostic marker of hepatocellular carcinoma and CDK4 inhibitors as potential therapeutics. Curr Med Chem. 2025;32:343–58.
Google ScholarÂ
Tian Q, Lu G, Ma Y, Ma L, Shang Y, Guo N, et al. Integrated analysis and validation of the TRIM28-H2AX-CDK4 diagnostic model assists to predict the progression of HCC. Aging. 2023;15:14617–50.
Google ScholarÂ
Calvisi D, Eferl R. CDK4/6 inhibition and sorafenib: a menage a deux in HCC therapy? GUT. 2017;66:1179–80.
Google ScholarÂ
Liu Y, DiStasio M, Su G, Asashima H, Enninful A, Qin X, et al. High-plex protein and whole transcriptome co-mapping at cellular resolution with spatial CITE-seq. Nat Biotechnol. 2023;41:1405–9.
Google ScholarÂ
Fan R, Zhang D, Rodriguez-Kirby L, Lin Y, Song M, Wang L, et al. Spatial dynamics of mammalian brain development and neuroinflammation by multimodal tri-omics mapping. Res Sq. 2024;12:rs.3.rs–4814866.
Fan R, Baysoy A, Tian X, Zhang F, Renauer P, Bai Z, et al. Spatially resolved panoramic in vivo CRISPR screen via perturb-DBiT. Res Sq. 2025;8:rs.3.rs–6481967.
